查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2008879

血管支架市場報告：按產品類型、材料、輸送方式、最終用戶和地區分類（2026-2034 年）

Vascular Stents Market Report by Product Type, Material, Mode of Delivery, End-User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3個工作天內

價格

2025年全球血管支架市場規模達117億美元。展望未來，IMARC Group預測，2026年至2034年該市場將以4.71%的複合年成長率成長，到2034年達到180億美元。該市場正經歷穩定成長，其促進因素包括心血管疾病（包括冠狀動脈疾病和周邊動脈疾病）盛行率的上升、人口老化趨勢以及為提升血管支架性能和安全性而開發的新材料、設計和塗層。

血管支架市場趨勢：

心血管疾病發生率增加

冠狀動脈疾病和周邊動脈疾病等心血管疾病的日益普及正在推動市場成長。由於久坐不動的生活方式、不健康的飲食習慣以及人口老化，這些疾病在全球範圍內呈上升趨勢。血管支架在治療這些疾病中發揮著至關重要的作用，它能夠恢復阻塞或狹窄動脈的血流。心血管疾病患者人數的不斷成長推動了全球對血管支架的需求。此外，隨著醫療專業人員和患者尋求有效且微創的治療方法，對血管支架的需求也不斷成長。這凸顯了支架技術的重要性及其在滿足日益受心血管疾病困擾的人群的醫療保健需求方面所發揮的關鍵作用。

人口老化和預期壽命延長

人口老化趨勢正在推動市場成長。老年人更容易罹患與老齡化相關的疾病，包括動脈粥狀硬化和其他血管疾病。血管支架，尤其是藥物釋放型和生物可吸收支架，對於有效治療老年人的這些疾病至關重要。預期壽命的延長以及醫療技術的進步，導致影響血管的慢性疾病盛行率上升。血管支架提供了一種微創治療方法，可以改善老年患者的血流並降低併發症風險。隨著醫療保健系統不斷適應老化社會的醫療需求，血管支架在這過程中發揮關鍵作用。

技術進步與產品創新

製造商不斷研發新型材料、設計和塗層，以提升血管支架的性能和安全性。此外，技術進步催生了藥物釋放型支架（DES）和生物可吸收支架的問世，這些支架透過減少血管再阻塞和最大程度地降低長期併發症，改善了患者的治療效果。同時，支架輸送系統和微創手術的創新也讓支架植入更安全、更有效率。因此，研發活動正在不斷湧現高性能的血管支架，為血管疾病提供更安全有效的治療選擇。此外，對能夠滿足個別患者需求並有助於改善臨床療效的客製化支架的需求日益成長，也為市場帶來了良好的前景。

糖尿病和肥胖症的盛行率

糖尿病和肥胖症的日益流行正在推動市場成長。糖尿病和肥胖症會導致心血管疾病，包括動脈粥狀硬化，而這些疾病通常需要使用血管支架進行治療。糖尿病由於血糖值升高及其相關併發症，也會導致冠狀動脈和周邊動脈疾病的發生。同樣，肥胖症與血管內斑塊的積聚有關，增加了動脈阻塞的風險，從而需要介入治療。此外，醫療專業人員正依靠支架來處理糖尿病和肥胖症患者出現的複雜血管問題，這也促進了市場成長。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 二手資訊
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球血管支架市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場區隔：依產品類型
  • 市場區隔：依材料分類
  • 市場區隔：依運輸方式
  • 市場區隔：依最終用戶分類
  • 市場區隔：按地區
  • 市場預測

第6章 市場區隔：依產品類型分類

  • 冠狀動脈支架
  • 周邊血管支架
  • EVAR血管支架

第7章 市場區隔：依材料分類

  • 金屬支架
    • 市場區隔：按類型
      • 鈷鉻合金
      • 鉑金鉻
      • 鎳鈦
      • 不銹鋼
  • 其他

第8章 市場區隔：依交付方式分類

  • 球囊擴張型支架
  • 自動擴張型支架

第9章 市場區隔：依最終用戶分類

  • 醫院和心臟中心
  • 門診手術中心

第10章 市場區隔：依地區分類

  • 北美洲
  • 歐洲
  • 亞太地區
  • 中東和非洲
  • 拉丁美洲

第11章 SWOT 分析

第12章：價值鏈分析

第13章：波特五力分析

第14章：價格分析

  • 價格指標
  • 價格結構
  • 利潤分析

第15章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Abbott Laboratories
    • B. Braun SE
    • Biosensors International Group Ltd.
    • Biotronik Se & Co. Kg
    • Boston Scientific Corporation
    • Endologix LLC
    • Lepu Medical Technology（Beijing）Co., Ltd.
    • Medtronic Plc
    • Meril Life Sciences Pvt. Ltd.
    • Microport Scientific Corporation
    • Terumo Corporation
    • Translumina Gmbh
    • WL Gore & Associates Inc.
Product Code: SR112026A1382

The global vascular stents market size reached USD 11.7 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 18.0 Billion by 2034, exhibiting a growth rate (CAGR) of 4.71% during 2026-2034. The market is experiencing steady growth driven by the increasing prevalence of cardiovascular diseases, such as coronary artery and peripheral artery, demographic shift towards an aging population, and development of new materials, designs, and coatings to enhance the performance and safety of vascular stents.

Vascular Stents Market Analysis:

  • Market Growth and Size: The market is witnessing moderate growth, which can be attributed to the increasing prevalence of cardiovascular diseases. In addition, the rising adoption of unhealthy lifestyles among individuals is propelling the growth of the market.
  • Technological Advancements: Innovations are leading to the development of advanced drug-eluting stents, which is enhancing the overall outcome. Moreover, the adoption of minimally invasive (MI) techniques to improve the stenting procedure is supporting the growth of the market.
  • Industry Applications: Vascular stents are used in coronary arteries, peripheral arteries, and other vascular areas. Besides this, they are vital in restoring blood flow and preventing complications, which is positively influencing the market.
  • Geographical Trends: North America leads the market on account of its well-established healthcare infrastructure. However, Europe is emerging as a fast-growing market, driven by the growing aging population.
  • Competitive Landscape: Key players in the market are actively engaged in several strategic initiatives to maintain their competitive edge. They are collaborating with healthcare institutions and physicians to conduct clinical trials and gather real-world data on stent performance, which is impelling the market growth.
  • Challenges and Opportunities: While the market faces challenges, such as regulatory hurdles for market players in terms of approvals and compliance, it also encounters opportunities in catering to the growing demand for stents in developing regions.
  • Future Outlook: The future of the vascular stents market looks promising, with technological advancements, coupled with an aging population.

Vascular Stents Market Trends:

Rising incidences of cardiovascular diseases

The increasing prevalence of cardiovascular diseases, such as coronary artery disease and peripheral artery disease, is strengthening the growth of the market. These conditions are rising worldwide due to sedentary lifestyles, unhealthy diets, and an aging population. Vascular stents play a crucial role in the treatment of these diseases by restoring blood flow to blocked or narrowed arteries. With numerous people affected by cardiovascular ailments, the demand for vascular stents is growing around the world. As healthcare providers and patients are seeking effective and minimally invasive (MI) solutions, there is a rise in the demand for vascular stents. This factor underscores the importance of stent technologies and their pivotal role in addressing the healthcare needs of a population with an increasing burden of cardiovascular disorders.

Aging population and increased longevity

The demographic shift towards an aging population is propelling the growth of the market. Elderly people are more susceptible to age-related conditions, including atherosclerosis and other vascular diseases. Vascular stents, especially drug-eluting and bioabsorbable varieties, are becoming vital in managing these conditions effectively in older adults. Longer life expectancy, coupled with advancements in healthcare, is leading to a higher prevalence of chronic diseases that affect blood vessels. Vascular stents offer a minimally invasive (MI) solution for improving blood flow and reducing the risk of complications in elderly patients. Healthcare systems are adapting to meet the healthcare needs of aging populations, and vascular stents play a crucial role in this effort.

Technological advancements and product innovations

Manufacturers are consistently developing new materials, designs, and coatings to enhance the performance and safety of vascular stents. In addition, technological advancements are leading to the development of drug-eluting stents (DES) and bioabsorbable stents, which offer improved patient outcomes by reducing restenosis and minimizing long-term complications. Additionally, innovations in stent delivery systems and minimally invasive (MI) procedures are making stent placement safer and more efficient. In line with this, research and development (R&D) activities are resulting in enhanced vascular stents that can provide safer and more effective treatment options for vascular diseases. Moreover, the growing demand for stents that are tailored as per specific patient needs, contributing to better clinical outcomes is offering a favorable market outlook.

Prevalence of diabetes and obesity

The increasing prevalence of diabetes and obesity is bolstering the growth of the market. Diabetes and obesity lead to cardiovascular diseases, including atherosclerosis, which often necessitates the use of vascular stents for treatment. Diabetes can also lead to the development of coronary artery disease and peripheral artery disease due to elevated blood sugar levels and associated complications. Similarly, obesity is linked to the accumulation of plaque in blood vessels, increasing the likelihood of arterial blockages that require intervention. Moreover, healthcare providers rely on stents to manage the complex vascular issues arising in individuals with diabetes and obesity, thereby contributing to the growth of the market.

Vascular Stents Industry Segmentation:

Breakup by Product Type:

  • Coronary Stents
  • Peripheral Vascular Stents
  • EVAR Stent Grafts

Coronary stents account for the majority of the market share

Peripheral vascular stents are designed to treat blockages and stenosis in arteries outside the heart, typically in the lower extremities, neck, and renal arteries. This segment addresses the needs of patients suffering from peripheral artery disease (PAD), a condition that affects blood flow in the limbs and organs. Minimally invasive (MI) procedures involving peripheral stents are gaining traction, providing a less invasive option for patients.

EVAR stent grafts are specialized devices used to treat aortic aneurysms. These stent grafts are deployed within the aorta to reinforce the weakened vessel wall, reducing the risk of aneurysm rupture. They also offer a less invasive alternative to open surgical procedures for managing aortic aneurysms, leading to quicker patient recovery and lower post-operative complications.

Breakup by Material:

  • Metallic Stents
    • Cobalt Chromium
    • Platinum Chromium
    • Nickel Titanium
    • Stainless Steel
  • Others

Metallic stents hold the largest share in the industry

Breakup by Mode of Delivery:

  • Balloon-Expandable Stents
  • Self-Expanding Stents

Balloon-expandable stents represent the leading market segment

Balloon-expandable stents are designed to be implanted using an angioplasty balloon catheter. When the stent is in the desired position within the artery, the balloon is inflated, causing the stent to expand and press against the arterial wall, keeping the vessel open. Balloon-expandable stents are widely used in coronary interventions and are preferred in situations where precise placement and control over stent deployment are critical. Their ability to provide accurate sizing and positioning within the vessel, contributing to successful procedures and improved patient outcomes.

Self-expanding stents are designed to expand automatically when deployed. They are typically made from materials with shape memory properties, such as nitinol, which allows them to self-expand and conform to the shape of the vessel. This segment of the market is particularly suitable for use in peripheral arteries and anatomical locations where precise placement can be challenging with balloon-expandable stents. Self-expanding stents are also favored for treating vessels with varying diameters or tortuous anatomy.

Breakup by End-User:

  • Hospitals and Cardiac Centers
  • Ambulatory Surgical Centers

Hospitals and cardiac centers exhibit a clear dominance in the market

Hospitals and cardiac centers serve as the primary hubs for complex cardiovascular procedures and interventions, including the implantation of vascular stents. The comprehensive infrastructure and specialized cardiac teams in hospitals make them well-equipped to handle a wide range of cases, ranging from emergency cardiac procedures to elective stent placements. Additionally, hospitals often have access to the latest technologies and equipment required for stent implantation and follow-up care, which further strengthens their position as the dominant end-users of vascular stents.

Ambulatory surgical centers (ASCs) are a growing segment in the market. These facilities offer outpatient surgical procedures, including vascular stent placements, in a more streamlined and convenient setting compared to traditional hospitals. ASCs are gaining traction due to their ability to provide cost-effective and patient-centered care. They are particularly suitable for less complex cases and elective procedures, allowing patients to undergo stent implantation and return home on the same day.

Breakup by Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

North America leads the market, accounting for the largest vascular stents market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. According to the report, North America accounts for the largest market share as the region benefits from a well-established healthcare infrastructure, high medical expenditure, and the increasing prevalence of cardiovascular diseases. The United States plays a pivotal role in driving the market growth, with a substantial patient population and extensive research and development (R&D) activities in the field of vascular stents. The presence of key market players and a focus on technological advancements are contributing to the growth of the market in the region.

Europe is another prominent region in the market, characterized by advanced healthcare systems and a growing aging population. Countries like Germany, France, and the United Kingdom are at the forefront of stent adoption. European regulations ensure rigorous product approvals and safety standards, fostering trust in stent technologies. Besides this, increasing preferences for minimally invasive (MI) treatment options is propelling the market growth across the region.

Asia Pacific represents a region with significant growth potential in the market. The increasing incidence of cardiovascular diseases in countries like India and China, coupled with expanding healthcare access, is catalyzing the demand for vascular stents. Moreover, advancements in healthcare infrastructure and rising awareness of minimally invasive (MI) procedures are strengthening the market growth in this region.

The Middle East and Africa exhibit a growing demand for vascular stents due to changing lifestyles and improvements in healthcare infrastructure. While the market in this region is relatively nascent, it is poised for development as healthcare systems are evolving and the need for vascular stent interventions is becoming more pronounced.

Latin America is another emerging market due to the growing healthcare investments and presence of both multinational and regional stent manufacturers, contributing to the market growth. As healthcare access is improving and awareness about vascular stent treatments is increasing, there is a rise in the demand for vascular stents in the region.

Leading Key Players in the Vascular Stents Industry:

Key players in the market are actively engaged in several strategic initiatives to maintain their competitive edge. They are investing in research and development (R&D) activities to introduce innovative stent technologies, including drug-eluting stents with advanced coatings to minimize restenosis rates and bioabsorbable stents that dissolve over time. Additionally, companies are expanding their geographical presence by entering emerging markets in Asia-Pacific and Latin America, where the demand for vascular stents is rising. Collaboration with healthcare institutions and physicians to conduct clinical trials and gather real-world data on stent performance is also increasing, aiming to demonstrate the effectiveness of their products. Overall, key players are committed to advancing vascular stent technology, expanding their market reach, and ensuring patient outcomes are improving.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Abbott Laboratories
  • B. Braun SE
  • Biosensors International Group Ltd.
  • Biotronik Se & Co. Kg
  • Boston Scientific Corporation
  • Endologix LLC
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Medtronic Plc
  • Meril Life Sciences Pvt. Ltd.
  • Microport Scientific Corporation
  • Terumo Corporation
  • Translumina Gmbh
  • W. L. Gore & Associates Inc.

Key Questions Answered in This Report

  • 1.How big is the vascular stents market?
  • 2.What is the future outlook of vascular stents market?
  • 3.What are the key factors driving the vascular stents market?
  • 4.Which region accounts for the largest vascular stents market share?
  • 5.Which are the leading companies in the global vascular stents market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Vascular Stents Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Product Type
  • 5.5 Market Breakup by Material
  • 5.6 Market Breakup by Mode of Delivery
  • 5.7 Market Breakup by End-User
  • 5.8 Market Breakup by Region
  • 5.9 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Coronary Stents
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Peripheral Vascular Stents
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 EVAR Stent Grafts
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Material

  • 7.1 Metallic Stents
    • 7.1.1 Market Trends
    • 7.1.2 Market Breakup by Type
      • 7.1.2.1 Cobalt Chromium
        • 7.1.2.1.1 Market Trends
        • 7.1.2.1.2 Market Forecast
      • 7.1.2.2 Platinum Chromium
        • 7.1.2.2.1 Market Trends
        • 7.1.2.2.2 Market Forecast
      • 7.1.2.3 Nickel Titanium
        • 7.1.2.3.1 Market Trends
        • 7.1.2.3.2 Market Forecast
      • 7.1.2.4 Stainless Steel
        • 7.1.2.4.1 Market Trends
        • 7.1.2.4.2 Market Forecast
    • 7.1.3 Market Forecast
  • 7.2 Others
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Mode of Delivery

  • 8.1 Balloon-Expandable Stents
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Self-Expanding Stents
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Hospitals and Cardiac Centers
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Ambulatory Surgical Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Europe
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Asia Pacific
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Middle East and Africa
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast
  • 10.5 Latin America
    • 10.5.1 Market Trends
    • 10.5.2 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

  • 14.1 Price Indicators
  • 14.2 Price Structure
  • 14.3 Margin Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
    • 15.3.2 B. Braun SE
    • 15.3.3 Biosensors International Group Ltd.
    • 15.3.4 Biotronik Se & Co. Kg
    • 15.3.5 Boston Scientific Corporation
    • 15.3.6 Endologix LLC
    • 15.3.7 Lepu Medical Technology (Beijing) Co., Ltd.
    • 15.3.8 Medtronic Plc
    • 15.3.9 Meril Life Sciences Pvt. Ltd.
    • 15.3.10 Microport Scientific Corporation
    • 15.3.11 Terumo Corporation
    • 15.3.12 Translumina Gmbh
    • 15.3.13 W. L. Gore & Associates Inc.

List of Figures

  • Figure 1: Global: Vascular Stents Market: Major Drivers and Challenges
  • Figure 2: Global: Vascular Stents Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Vascular Stents Market: Breakup by Product Type (in %), 2025
  • Figure 4: Global: Vascular Stents Market: Breakup by Material (in %), 2025
  • Figure 5: Global: Vascular Stents Market: Breakup by Mode of Delivery (in %), 2025
  • Figure 6: Global: Vascular Stents Market: Breakup by End-User (in %), 2025
  • Figure 7: Global: Vascular Stents Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Vascular Stents Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 9: Global: Vascular Stents Industry: SWOT Analysis
  • Figure 10: Global: Vascular Stents Industry: Value Chain Analysis
  • Figure 11: Global: Vascular Stents Industry: Porter's Five Forces Analysis
  • Figure 12: Global: Vascular Stents (Coronary Stents) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Vascular Stents (Coronary Stents) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Vascular Stents (Peripheral Vascular Stents) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Vascular Stents (Peripheral Vascular Stents) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Vascular Stents (EVAR Stent Grafts) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Vascular Stents (EVAR Stent Grafts) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Vascular Stents (Metallic Stents) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Vascular Stents (Metallic Stents) Market: Breakup by Type (in %), 2025
  • Figure 20: Global: Vascular Stents (Cobalt Chromium) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Vascular Stents (Cobalt Chromium) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Vascular Stents (Platinum Chromium) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Vascular Stents (Platinum Chromium) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Vascular Stents (Nickel Titanium) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Vascular Stents (Nickel Titanium) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Vascular Stents (Stainless Steel) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Vascular Stents (Stainless Steel) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Vascular Stents (Metallic Stents) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Vascular Stents (Other Material Types) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Vascular Stents (Other Material Types) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Global: Vascular Stents (Balloon-Expandable Stents) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Global: Vascular Stents (Balloon-Expandable Stents) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Global: Vascular Stents (Self-Expanding Stents) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Global: Vascular Stents (Self-Expanding Stents) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Global: Vascular Stents (Hospitals and Cardiac Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Global: Vascular Stents (Hospitals and Cardiac Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Global: Vascular Stents (Ambulatory Surgical Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Global: Vascular Stents (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: North America: Vascular Stents Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: North America: Vascular Stents Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Europe: Vascular Stents Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Europe: Vascular Stents Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Asia Pacific: Vascular Stents Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Asia Pacific: Vascular Stents Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Middle East and Africa: Vascular Stents Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Middle East and Africa: Vascular Stents Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Latin America: Vascular Stents Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Latin America: Vascular Stents Market Forecast: Sales Value (in Million USD), 2026-2034

List of Tables

  • Table 1: Global: Vascular Stents Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Vascular Stents Market Forecast: Breakup by Product Type (in Million USD), 2026-2034
  • Table 3: Global: Vascular Stents Market Forecast: Breakup by Material (in Million USD), 2026-2034
  • Table 4: Global: Vascular Stents Market Forecast: Breakup by Mode of Delivery (in Million USD), 2026-2034
  • Table 5: Global: Vascular Stents Market Forecast: Breakup by End-User (in Million USD), 2026-2034
  • Table 6: Global: Vascular Stents Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Vascular Stents Market Structure
  • Table 8: Global: Vascular Stents Market: Key Players